Skip to main content
Premium Trial:

Request an Annual Quote

Qatar Center to Use Illumina Genotyping Platform to Study Arabian Gulf Region Founder Populations

NEW YORK, May 9 (GenomeWeb News) - Illumina said today that the genetic facility at the Shafallah Center for Children with Special Needs in Doha, Qatar, has installed an Illumina BeadLab genotyping platform.


The Shafallah Center will use the BeadLab as part of its research on rare autosomal recessive diseases as well as complex diseases such as diabetes, Illumina said.


All disease research at the facility will involve the collection and analysis of clinical, genetic, and family history data. The ShafallahGeneticsMedicalCenterwill have access to samples from founder populations indigenous to the Persian Gulf region, Illumina said.


Financial terms were not disclosed.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.